Potential impact of the bivalent rLP2086 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease

Lignende værker

• Meningococcal Serogroup B Bivalent rLP2086 Vaccine Elicits Broad and Robust Serum Bactericidal Responses in Healthy Adolescents
  af: Vesikari, Timo, et al.
  Udgivet: (2016)
• Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine
  af: McNeil, Lisa K., et al.
  Udgivet: (2018)
• Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis serogroup C disease
  af: Harris, Shannon L, et al.
  Udgivet: (2011)
• Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086)
  af: Cendron, Laura, et al.
  Udgivet: (2011)
• Immunogenicity, Safety, and Tolerability of Bivalent rLP2086 Meningococcal Group B Vaccine Administered Concomitantly With Diphtheria, Tetanus, and Acellular Pertussis and Inactivated Poliomyelitis Vaccines to Healthy Adolescents
  af: Vesikari, Timo, et al.
  Udgivet: (2016)